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a b s t r a c t
The products of Hox genes function in assigning positional identity along the anterior–posterior body
axis during animal development. In mouse embryos, Hox genes located at the 3′ end of HoxA and HoxB
complexes are expressed in nested patterns in the progenitors of the secondary heart ﬁeld during early
cardiogenesis and the combined activities of both of these clusters are required for proper looping of the
heart. Using Hox bacterial artiﬁcial chromosomes (BACs), transposon reporters, and transgenic analyses
in mice, we present the identiﬁcation of several novel enhancers ﬂanking the HoxB complex which can
work over a long range to mediate dynamic reporter expression in the endoderm and embryonic heart
during development. These enhancers respond to exogenously added retinoic acid and we have
identiﬁed two retinoic acid response elements (RAREs) within these control modules that play a role
in potentiating their regulatory activity. Deletion analysis in HoxB BAC reporters reveals that these
control modules, spread throughout the ﬂanking intergenic region, have regulatory activities that overlap
with other local enhancers. This suggests that they function as shadow enhancers to modulate the
expression of genes from the HoxB complex during cardiac development. Regulatory analysis of the HoxA
complex reveals that it also has enhancers in the 3′ ﬂanking region which contain RAREs and have the
potential to modulate expression in endoderm and heart tissues. Together, the similarities in their
location, enhancer output, and dependence on retinoid signaling suggest that a conserved cis-regulatory
cassette located in the 3′ proximal regions adjacent to the HoxA and HoxB complexes evolved to
modulate Hox gene expression during mammalian cardiac and endoderm development. This suggests a
common regulatory mechanism, whereby the conserved control modules act over a long range on
multiple Hox genes to generate nested patterns of HoxA and HoxB expression during cardiogenesis.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Hox genes code for transcription factors whose differential
expression during early embryogenesis assigns positional identity
along the body axis. In mammals, there are 39 genes organized
into four complexes (A, B, C, and D) with each complex containing
from 9 to 11 genes (Krumlauf, 1994). There is an association
between their chromosomal organization and sequential activa-
tion known as colinearity (Duboule and Dollé, 1989; Graham et al.,
1989; Kmita and Duboule, 2003). This regulatory feature is used in
many tissues and organs to establish a nested complement of Hox
proteins along embryonic axes that forms part of a molecular code
for speciﬁcation of positional information (Alexander et al., 2009;
Zakany and Duboule, 2007; Mallo et al., 2010; Wellik, 2009).
Retinoic acid (RA) signaling plays an important role in establishing
the initial patterns of expression of Hox genes in the neural
ectoderm, mesoderm and endoderm (Alexander et al., 2009;
Deschamps and van Nes, 2005; Huang et al., 1998; Tümpel et al.,
2009). Experimental manipulation of RA levels or inactivation of
components involved in RA signaling and metabolism result in
changes in patterns of Hox expression during early develop-
ment (Rhinn and Dolle, 2012; Sirbu et al., 2005). For some of
these Hox genes, input from RA signaling is directly mediated by
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cis-regulatory sequences known as retinoic acid response elements
(RAREs) (reviewed in Tümpel et al. (2009)).
The heart is one of the ﬁrst organs to develop in the vertebrate
embryo (Buckingham et al., 2005; Vincent and Buckingham, 2010).
Its construction originates from four different regions of the
developing embryo. Two of these regions, the ﬁrst and second
heart ﬁeld are derived from the splanchnic mesoderm. The ﬁrst
heart ﬁeld (FHF) gives rise to the heart tube and subsequently the
left ventricular myocardium. Cells from the second heart ﬁeld
(SHF) use the heart tube as a scaffold in which to migrate and
contribute to the myocardium of the atria, right ventricle and
outﬂow tract (OFT). In addition to these two mesodermally-
derived ﬁelds, cells from the cardiac neural crest and the proepi-
cardial organ (PEO) make contributions. The cardiac neural crest
cells contribute to the musculature of the arteries connected to the
heart and are required for the correct morphology and septation of
the cardiac outﬂow tract in birds and mammals (reviewed in
Creazzo et al. (1998) and Stoller and Epstein (2005)). The PEO is a
temporary mesenchymal population of cells derived from the
septum transversum, located posterior to the developing heart.
Cells from the PEO migrate and form the outer lining of the heart,
the epicardium.
Endoderm plays a crucial role during cardiogenesis, both as a
physical substrate over which cells of the cardiogenic mesoderm
migrate, as well as a source of instructive factors that regulate the
cardiac speciﬁcation and differentiation program (Dunwoodie,
2007). Both early endoderm progenitors and pre-cardiac meso-
derm are speciﬁed in close proximity to one another within the
anterior region of the primitive streak (Varner and Taber, 2012).
Concurrently early Hox gene expression is initiated in the cells
ingressing through the node (Deschamps and van Nes, 2005).
As development proceeds, collinear Hox gene expression becomes
regionalized during endoderm development and correlates with
local features of the developing gut and genitalia (Dollé et al.,
1991; Grapin-Botton, 2005). Loss- and gain-of-function studies of
Hox genes have demonstrated roles in patterning a variety of
endodermal tissues, such as the thymus, esophagus, stomach,
intestine and genitalia and both the ileo-caecal and anal sphincters
(Aubin et al., 2002; Boulet and Capecchi, 1996; Kondo et al., 1996;
Manley and Capecchi, 1998; Wolgemuth et al., 1989; Zacchetti
et al., 2007; Zakany and Duboule, 1999; Zákány et al., 2001).
Hox genes are expressed throughout the splanchnic mesoderm,
rhombomeres (origin of cardiac neural crest cells), and the septum
transversum – tissues from which progenitors of the heart
originate. Hox gene expression in the heart was ﬁrst characterized
in the chick embryo, where Hoxd3, Hoxa4 and Hoxd4 were
detected during early cardiogenesis (Searcy and Yutzey, 1998).
Subsequently, Hoxa1, Hoxb1 and Hoxa3 have been shown to be
expressed in the cardiac progenitors of the mouse heart (Bertrand
et al., 2011) where their descendants populate the atria and OFT.
These nested expression patterns suggest that multiple Hox
proteins may modulate aspects of the cardiac developmental
program. However, few cardiac defects have been reported as a
result of Hox mutations. In the mouse, targeted disruption of the
Hoxa3 gene results in heart and artery defects, primarily due to
changes in the fate of the cranial neural crest cells that normally
express Hoxa3 (Chisaka and Capecchi, 1991). Mutations in the
HOXA1 gene result in human cardiovascular defects that include
malformations of the OFT and the arteries connected to the heart
(Tischﬁeld et al., 2005). Recently, a re-evaluation of the Hoxa1
mouse mutant revealed phenotypes that closely model those
observed in the human HOXA1 syndrome patients (Makki and
Capecchi, 2012). These studies highlight roles for the Hoxa1 and
Hoxa3 genes in patterning progenitors arising from the contribu-
tion of the cardiac neural crest cells to the heart. The absence of
signiﬁcant heart phenotypes in single targeted mutants appears to
be due to functional compensation by other genes or clusters.
Deletion of either the HoxA or HoxB complexes does not result in
enhanced heart phenotypes compared to the individual gene
mutations. In contrast, the speciﬁc compound deletion of both
the HoxA and HoxB complexes results in mouse embryos that fail
to undergo proper heart looping (Soshnikova et al., 2013). Other
variants of double cluster deletions do not present these heart
defects, revealing a speciﬁc combined role for multiple members
from the HoxA and HoxB complexes in heart morphogenesis.
Heart looping defects are seen in mouse embryos deﬁcient in
RA signaling. In the absence of functional retinaldehyde dehydro-
genase 2 (Raldh2), the enzyme that converts retinaldehyde into
retinoic acid, the heart tube forms but fails to undergo looping
(Niederreither et al., 1999, 2001). In Raldh2 null mutant embryos,
the gene expression proﬁle of the SHF is altered suggesting a
posterior expansion of the ﬁeld (Ryckebusch et al., 2008). The role
of RA signaling in determining the size of the heart ﬁeld and
regulating the position of the posterior domain of the cardiac ﬁeld
is conserved in other vertebrate models (Yutzey et al., 1994). The
inﬂuence of RA on heart development may be partially mediated
through its effects on Hox genes. RA signaling has an indirect role
in determining the size of the cardiac ﬁeld mediated by its
regulation of Hoxb5b expression in the adjacent forelimb ﬁeld
(Keegan et al., 2005; Waxman et al., 2008). In the absence of RA,
there is reduction in the forelimb ﬁeld and a posterior expansion
of the cardiac ﬁeld, revealing retinoid dependent communications
between these adjacent ﬁelds. In the mouse, Raldh2 null mutant
embryos Hoxa1 is no longer expressed in the SHF (Ryckebusch
et al., 2008). Recently, an RA responsive enhancer for the Hoxa3
gene has been characterized and shown to direct lacZ expression
in cardiac neural crest cells and the SHF (Diman et al., 2011). RA
signaling is also important for regionalization of the endoderm
and formation of the pancreas (Kinkel et al., 2009; Stafford et al.,
2006).
Together these studies suggest that RA-directed expression of
Hox genes is important for patterning and morphogenesis of the
endoderm and heart. However, with the exception of the murine
Hoxa3 gene (Diman et al., 2011), no enhancers capable of mediat-
ing Hox expression in the progenitors of the developing heart have
been identiﬁed. Similarly, few regulatory regions for the directed
expression of Hox genes in endoderm derivatives have been
characterized (Huang et al., 1998). Here we report the identiﬁca-
tion of several novel enhancers from the HoxA and HoxB complex
that mediate reporter expression in endoderm and regions that
are sources of cardiac progenitors, including the proepicardial
organ (PEO) and splanchnic mesoderm, as well as in the OFT and
epicardium of the embryonic heart. These enhancers contain
RAREs, suggesting that they integrate inputs from retinoid signal-
ing while modulating HoxA and HoxB expression during heart
development and endoderm patterning.
Materials and methods
Comparative genomics analysis
Comparative genomic analysis was performed at the mVISTA
website using the LAGAN alignment tool (http://genome.lbl.gov/).
The genomic sequences used in the alignments were downloaded
from the Ensembl website (http://www.ensembl.org/) and
imported into VectorNTi.
Transposon insertions in HoxB BACs
The technique used to generate the lacZ reporter transposon
studded HoxB BACs has been previously described (Morgan et al.,
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1996). The original host strain, HB101 (endAþ), was substituted
with HB10B as it resulted in BAC DNA instability. The BAC used in
this study (MMP-5) was isolated from a 129SV mouse BAC library
(Research Genetics, USA; for further details please see Parrish et al.
(2011)). Reporter integrations were initially screened by alkaline
lysis mini preparatory analysis, taking advantage of an internal
SmaI site within the lacZ transposon to identify BAC clones
in which the transposon had integrated downstream of the HoxB
complex. The actual site of transposon integration was identiﬁed
by sequencing outwards from the 5′ and 3′ ends of the integra-
ted transposon using the γ and Δ oligonucleotides described in
Morgan et al. (1996).
BAC deletion constructs
Two different types of deletions were generated using the
recombinogenic bacterial strains, EL250 and EL350, from the Neal
Copeland laboratory (Lee et al., 2001). Deletion of the 3′ Hoxb1
enhancers was accomplished by using a replacement strategy such
that these elements were exchanged for an Frt ﬂanked kanamycin
selection cassette (derived from pIGCN21). Once positive clones
were identiﬁed, the kanamycin selection cassette was removed by
growing in 3 ml LB cultures supplemented with 0.1 M sucrose for
1 h at 32 1C. In the second type of deletion, the novel regions
downstream of the HoxB complex that displayed enhancer activity
were deleted using a loxP ﬂanked kanamycin–neomycin cassette.
Capture constructs and generation of successive 3′ truncations
To generate the 10 kb reporter constructs and truncated varia-
tions, oligonucleotide cassettes were designed to ‘capture’ the
region of interest from a BAC spanning the region between Hoxb1
and Skap1 into pBGZ40 (Yee and Rigby, 1993) using recombino-
genic bacterial strain DY380 (Lee et al., 2001). These oligonucleo-
tide cassettes contain a 5′ and 3′ 47 nucleotide long homology arm
corresponding to the ﬂanking ends of the region to be ‘captured’
separated by an unique SalI site. This ‘capture’ technique did not
work to clone Region 6 as we could not propagate the clone in
bacteria. Additional approaches, such as PCR ampliﬁcation and
direct subcloning from the BAC, also failed to generate a propag-
able plasmid containing Region 6.
Preparation of DNA for microinjections, transgenesis and
β-galactosidase staining assays
The BAC DNA from positive clones was prepared using the
QIAGEN Maxi prep kit with the following modiﬁcations. Bacteria
from a 300 ml overnight culture were pelleted and resuspended in
30 ml of P1 buffer. The volumes of the subsequent buffers (P2 and
P3) were each increased to 30 ml, while the incubation time
following the addition of P3 was reduced to 10 min. BAC DNA
was eluted from the column with 65 1C warmed QF solution.
BAC DNA was prepared for microinjection by loading onto a
QIAquick PCR puriﬁcation kit and then eluting it in 50 1C pre-
warmed microinjection buffer. Following quantitation, it was
subsequently diluted in BAC microinjection buffer to a concentra-
tion of 1–2 ng/ml for pronuclear microinjections. Plasmid based
reporter fragments were separated from vector sequence by gel
electrophoresis and the inserts extracted from agarose using
MinElute (Qiagen). For microinjections they were prepared using
the same method used for BAC DNA except they were resuspended
in microinjection buffer without the addition of spermidines.
Transgenic embryos and founders were generated by pro-nuclear
injection of linearized constructs into fertilized eggs of C57Bl/10J
xCBA-F1 crosses and reimplanted into pseudopregnant foster
mothers.
To detect β-galactosidase activity, embryos were ﬁxed in either
0.1% paraformaldehyde/0.2% glutaraldehyde (E11.5–E13.5) or 4%
paraformaldehyde (PFA) (E14.0 or older) for 30–60 min on ice.
After several washes in phosphate buffered saline, samples were
stained in X-Gal for 4–20 h at 4 1C or at room temperature (Ahn
et al., 2013; Whiting et al., 1991). The frequency of transgenic
embryos was determined by PCR reactions using primers against
the lacZ sequence of the β-galactosidase reporter.
Retinoic acid gavage
Pregnant transgenic dams were feed all-trans retinoic acid
(Sigma Aldrich, R2625) ﬁrst dissolved in DMSO and then diluted
in sesame seed oil with a ﬁnal concentration of 20 mg/kg of body
weight. Treatment times were performed 6 h prior to collecting
E7.5 and E9.5 embryos for lacZ expression assays.
Mutation of RARE sequences
The novel RARE sequences were mutated by PCR overlap
extension (Ho et al., 1989). Oligonucleotides were designed such
that the direct repeat nucleotides were converted to adenines.
Clones were sequenced for conﬁrmation of mutation of the RARE
sequence before being ligated back into the lacZ reporter plasmid
and prepared for pronuclear microinjections.
Results
The goal in this study was to identify regulatory regions which
could participate in the regulation of HoxB and HoxA genes in heart
and endoderm development. Our previous regulatory analyses of
the Hox complexes uncovered a variety of local embedded enhan-
cers that mediated restricted expression in a variety of tissues
(Tümpel et al., 2009) but none within the developing embryonic
heart. It is possible that global control regions or enhancers
working at long range, analogous to those for HoxD expression
in the limb (Zakany and Duboule, 2007), may be involved in
mediating heart expression; therefore, we explored the cis-reg-
ulatory potential of the 3′ ﬂanking intergenic regions adjacent to
the most anteriorly expressed genes.
Comparative analysis of the region ﬂanking the HoxB complex
between placental mammals
Phylogenetic footprinting is a useful tool to search for potential
enhancer regions based on sequence conservation. Analysis with
the VISTA comparative genomics program, using mouse as a
reference sequence, revealed numerous blocks of conservation
spanning the entire intergenic region between Hoxb1 and Skap1
(Fig. 1), its next non-Hox neighbor gene whose expression is
restricted to T-lymphocytes, mast cells and macrophages (Wang
and Rudd, 2008). These blocks of sequence varied in size and
location but were unique to placental mammals as few of them
were conserved when the mouse was used a reference sequence
against representative non-placental vertebrates, such as turtle
and ﬁsh (Fig. 1C).
The ﬁrst 5 kb of sequence at the 5′ end of this intergenic
interval displays multiple peaks of conservation which correspond
to three previously identiﬁed local enhancers of the Hoxb1 gene.
These are located 3′ of the gene and are responsible for its
expression in the neural tube, mesoderm and foregut endoderm
(Gavalas et al., 1998; Huang et al., 1998; Marshall et al., 1994;
Studer et al., 1998). We observed a similar level of broad con-
servation spread throughout the entire intergenic region between
Hoxb1 and Skap1 (Fig. 1B). These blocks of conserved sequence
C. Nolte et al. / Developmental Biology 383 (2013) 158–173160
could correspond to several types of elements such as enhancers,
pseudogenes, long noncoding RNAs, scaffold/matrix attachment
regions, insulators and boundary elements maintained during the
mammalian lineage. In fact, the conserved blocks at 22 and 80 kb
correspond to a known pseudogene (Gm11531) and the 3′ end of
long noncoding RNA (Gm11529), respectively. In light of this
extensive conservation throughout the intergenic region it was
not possible to focus on any particular area as a candidate for
regulatory activity in the heart and endoderm. Therefore, it was
necessary to utilize alternative approaches to functionally test the
regulatory potential within this intergenic region.
Transposon-reporter assay of the region ﬂanking the HoxB complex
To assay the regulatory potential of this region at different
intervals we generated a library of transposon insertions (TIs) into
a BAC clone (MMP-5) that contained the 3′ half of the HoxB
complex (i.e., Hoxb5 to Hoxb1) as well as 80 kb of the ﬂanking
intergenic region downstream of the Hoxb1 gene (Fig. 1A).
The transposon contained a lacZ reporter under the control of a
β-globin minimal promoter (serving as an enhancer trap) and
randomly integrated as a single copy once per BAC molecule
(Morgan et al., 1996). Precise integration sites were determined
and several clones that contained the lacZ-reporter transposed at
10 kb (TI-1), 21 kb (TI-2), 26 kb (TI-3), 52 kb (TI-4) and 64 kb (TI-5)
downstream of the Hoxb1 gene were chosen for transgenic
analysis (Fig. 2A).
The transposon reporter integrated closest to the HoxB complex,
TI-1, displayed strong lacZ expression in the presumptive foregut
region, neural epithelium and somitic mesoderm (Fig. 2B) in a
pattern predicated from transgenic analyses of the previously
characterized individual 3′ enhancers of Hoxb1 (Gavalas et al.,
1998; Huang et al., 1998; Marshall et al., 1994; Studer et al., 1998).
This indicated that the TI-1 transposon was successfully integrating
regulatory inﬂuences from these known local Hoxb1 enhancers.
Despite differences in the integration site or orientation of the
reporter the overall expression pattern in E9.5 transgenic mouse
embryos of the other four transposon insertions (TI-2 to TI-5) was
similar, with lacZ expression throughout the posterior trunk
(Fig. 2B). Reporter expression was strong throughout the presomitic
mesoderm of the tail bud and became progressively restricted to the
ventral aspect of the somites, extending in TI-1 to TI-4 up to, and
Fig. 1. VISTA analysis of the intergenic region between Hoxb1 and Skap1. (A) A genomic map illustrating the relationship between the HoxB complex and the ﬁrst exon of the
Skap1 gene. Below it, the approximate range of the BAC (MMP-5) modiﬁed and used in this study to examine the regulatory potential of the region between Hoxb1 and
Skap1. (B) Comparison of intergenic sequences from available placental mammals, using the mouse as the reference sequence, show high level of sequence conservation
within the region between Hoxb1 and Skap1. (C) This level of sequence conservation is not observed when a similar VISTA comparison of non-mammal vertebrates is
performed against the mouse. In (B) the known local enhancers of the Hoxb1 gene that drive its expression during development are indicated as a redhead arrow (neural
tube enhancer), green box (mesoderm/endoderm enhancer) and yellow arrowhead (foregut endoderm enhancer). Also illustrated, as gray boxes above the placental
vertebrate comparison, are a pseudogene (Gm11531) and the 3′ end of a noncoding RNA (Gm11529).
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including, the territory adjacent to the forelimb bud. In TI-5, this
anterior domain was slightly posteriorized. Although the overall
pattern was similar between the TI reporters, there were important
reproducible differences between the sites of integration. BAC
reporters TI-2, TI-3 and TI-4 produced strong expression in the
septum transversum (Fig. 2B, white asterisk) and visceral endoderm
which was not observed with TI-1. In addition, TI-3 and TI-4
displayed β-galactosidase activity throughout the visceral mesoderm
whereas in TI-2 expression in the visceral mesoderm was restricted
to the domain in the septum and absent from the posterior regions.
In TI-4 and TI-5, a small group of lacZ expressing cells lining the
dorsal aorta was observed (Fig. 2B, black arrows).
The similarities and differences in the patterns of reporter
expression of these transposons suggest that they maybe integrat-
ing regulatory inﬂuences from known enhancers and other
elements spread over a broad region ﬂanking the HoxB cluster.
The common overall pattern of expression shared by these
transposons could be the result of the known local 3′ Hoxb1
enhancers acting over longer distances to mediate lacZ expression.
To directly evaluate this possibility, we deleted a 4.4 kb region
encompassing the local Hoxb1 3′ enhancers from three of the TI
BAC constructs to assay its input on expression (Fig. 2A). In all
three lines with this deletion, the major domains of reporter
expression remained remarkably similar (Fig. 2C). While expres-
sion in the tail bud presomitic region remained strong, the somitic
domain of expression was weakened and posteriorized such that
its anterior border aligned to the caudal side of the developing
forelimb bud. Expression in the visceral mesoderm, endoderm and
the septum transversum was greatly reduced or abolished. The
foregut domain of lacZ expression present in TI-1 (Fig. 2B, black
arrowhead) was signiﬁcantly reduced in TI-1Δ3′ indicating that
this domain of expression was primarily generated by the Hoxb1 3′
endodermal enhancer (Huang et al., 1998) deleted in this con-
struct. The changes in reporter expression arising from deletion of
the 3′ proximal Hoxb1 enhancers revealed that they are capable of
exerting regulatory inﬂuences over a long range.
Identiﬁcation of new endoderm and heart enhancers ﬂanking HoxB
The observation that transposons bearing the deletion of the
known elements displayed very similar expression patterns, sug-
gested that additional regulatory modules with overlapping activities
may be present in this HoxB ﬂanking region. To screen for this
potential, we divided the 80 kb of the intergenic region into a series
of overlapping 10 kb constructs and tested these in transgenic lacZ
reporter assays (Fig. 3A). Of the seven 10 kb reporters that we tested
(Region 6 was unclonable), Regions 1–4, corresponding to the ﬁrst
40 kb ﬂanking the Hoxb1 gene, displayed reproducible and indepen-
dent patterns of expression (Fig. 3B–E). Region 1, which contains the
previously characterized Hoxb1 3′ enhancers, produced the expected
lacZ expression throughout the trunk mesoderm and foregut endo-
derm (Fig. 3B). Region 2 produced a small patch of lacZ stained cells
in the visceral endoderm and proepicardial organ (PEO) (Fig. 3C,
white arrowhead). The lacZ expression pattern of Region 3 included
domains in the ectoderm of the branchial arches, the viscercal
endoderm, the PEO, and the epicardium (Fig. 3D). Region 4 produced
lacZ expression in the wall of the dorsal aorta (Fig. 3E, black arrow)
and in a small patch of cells located in the ventral–medial aspect of
the developing heart (Fig. 3E, open arrow).
This transgenic analysis revealed multiple regions with regu-
latory potential. Some of these corresponded to novel domains of
expression found in the transposon scanning assay. For example,
Regions 2 and 3 (Fig. 3C–D) displayed the visceral endoderm/
septum transversum lacZ expression patterns seen in TI-2, TI-3 and
TI-4 (Fig. 2B). However, by examining these as independent
fragments we also observed patterns of reporter activity that were
not detected in the context of the transposon assay. This suggests
they may need to work in context with surrounding elements to
mediate appropriate patterns of expression.
In an attempt to delineate where within Regions 2–4, enhancer
activity was concentrated, a series of subclones were generated
involving successive 5′ or 3′ truncations (Fig. 4). For Regions 2 and
3, deletions of any sequence abolished reporter activity suggesting
that multiple cis-elements are required for their regulatory poten-
tial. In contrast, 3′ deletions of Region 4 revealed a small 5′
fragment (4A) with expanded regulatory potential compared to
the entire 10 kb Region 4 (Figs. 4 and 5). We noted from the VISTA
sequence alignment that there was signiﬁcant conservation within
4A (Fig. 4A). Furthermore, this conservation extended into the 3′
sequences of Region 3 which when deleted (3B) abolished activity
(Fig. 4B). Therefore, we generated another reporter construct
containing the 3′ end of Region 3 and the 4A subclone, which
we called HGE (Fig. 4). This combination of regions resulted in
reporter staining that displayed different dynamics and patterns
compared to Region 3 or 4A alone (Fig. 5).
Temporal dynamics of enhancer activity in endoderm and
components of the embryonic heart
To monitor the patterns of expression mediated by these
regulatory regions during development we generated transgenic
reporter lines and characterized their expression in whole mount
embryos (Fig. 5). Region 3 displayed robust lacZ expression in the
visceral ectoderm as well as in the lateral mesoderm, but was not
expressed in the somites, neural tissues or tail bud at E8.5 (Fig. 5). At
this stage lacZ expression is apparent in the splanchnic mesoderm
that contributes to the SHF (Fig. 5, black square brackets). By E9.5
Region 3 mediated staining in the ectoderm overlaying the branchial
arches, the epicardium, the PEO, and visceral endoderm. This overall
pattern was maintained through E10.5 but new staining was
detected in some of the developing somites. By E11.5, there was
an upregulation in the somites and new domains of lacZ expression
appeared near the eye and in the presumptive future cranial suture.
We detected no expression in embryos at E8.5 in the Region
4 reporter line. However, Region 4 mediated expression in a small
patch of cells located medial lateral to the developing heart and
robust expression in the dorsal aorta from E9.5 to E10.5. At E11.5
reporter staining is signiﬁcantly reduced and is absent at later
stages. A smaller 5′ fragment of Region 4 (4A) did not direct lacZ
expression in the dorsal aorta, but in contrast mediated expression
in the epicardium of the heart from E9.5 to E11.5 (Fig. 5) with
earlier expression at E8.5 appearing in the anterior intestinal
Fig. 2. Transposon-lacZ BAC reporter constructs and their expression patterns in transgenic mouse embryos at E9.5. (A) Several clones of the MMP-5 BAC with the integrated
transposon-lacZ reporter at different positions downstream of the Hoxb1 gene were used in transient BAC transgenic assays to assay the regulatory potential of this region.
The position and orientation of the transposon-lacZ reporters are indicated as white arrows. The frequency of expressors over transgenic embryos is displayed to the right
side of each BAC construct (exp/Tgþ). The local 3′ enhancers of Hoxb1 and their approximate size are indicated as red (neural), green (mesoderm/endoderm) and yellow
(foregut endoderm) boxes. Depicted above them are representations of E9.5 mouse embryos with their expression pattern, and below them, their core regulatory sequence/
transcription factor listed in brackets. (B) The overall pattern of lacZ expression in E9.5 embryos was similar regardless of the site of reporter integration. As a morphological
landmark, the forelimb bud of each embryo (except for TI-3) is highlighted with a dotted, white line. In embryos bearing the TI-1 BAC, the black arrowhead points at the
domain of foregut expression driven by the local Hoxb1 DR5 RARE 3′ enhancer which is lost in embryos bearing the deletion of the area (TI-1Δ3′). In TI-5 and TI-4Δ3′
transgenic embryos, the black arrow points to lacZ expressing cells ﬂanking the dorsal aorta. The white asterisk indicates the septum transversum. (C) Deletion of the known
Hoxb1 enhancers results in a posterior shift in the expression of the BAC transposon-lacZ reporters, but does not eliminate its activity.
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portal (marked by a black chevron). It also produced strong
expression in the PEO at E9.5, and at E11.5 additional domains of
staining appeared in developing forelimb and hindlimb buds.
These temporal and tissue speciﬁc differences in the patterns of
reporter expression between Region 4 and 4A imply that elements
positioned within the 3′ part of Region 4 play a role in modulating
the enhancer readout of the 5′ components of this region.
The HGE reporter line carrying the enhancer spanning the 3′
end of Region 3 and 4A displayed a highly dynamic pattern of
expression (Fig. 5). At E8.5 there was no expression. Discrete
patches of cells ﬂanking the developing heart appeared at E9.5 and
these coalesced into groups of cells at E10.5. These lacZ expressing
cells were present in the visceral endoderm, visceral mesoderm
and within the developing E9.5 heart under the right side of the
loop. The clonal populations of β-galactosidase marked cells were
reminiscent of the knock-in of lacZ into the α-cardiac actin gene
(Meilhac et al., 2003) which produced patches of lacZ-stained
clones in the myocardium of the developing heart. There was a
dramatic expansion of reporter staining at E11.5. Robust staining
was seen in the ectoderm and endoderm, as well as in the
surrounding epicardium of the heart and the dorsal aspect of the
OFT. This resembles the pattern of expression produced by Region
3 at E9.5, except it had an anterior border of expression that
incorporated the ﬁrst branchial arch and surrounding tissues.
Together the results of the isolated enhancers and deleted
variations suggest complex interactions are at play in this regula-
tory landscape ﬂanking the HoxB complex. While some fragments
in the enhancer scanning assay did not display regulatory activity,
they may contain elements that cooperate with the components
that we have uncovered to potentiate regulatory activity. This type
of context dependent interaction both within and between these
regulatory modules is reminiscent of a “holo-enhancer” described
for Fgf8 (Marinic et al., 2013).
The newly identiﬁed control regions function as shadow enhancers
The results from the 10 kb scanning analysis of regulatory
potential indicate that a number of previously unidentiﬁed cis-
acting modules reside within the area deﬁned by Regions 2–4.
In light of the difﬁculties we encountered in attempting to further
Fig. 3. Transgenic analysis of 10 kb subclones derived from the Hoxb1-Skap1 intergenic region and their expression pattern in E9.5 mouse embryos. The 80 kb region
immediately downstream of the coding sequence of the Hoxb1 gene was divided into eight 10 kb Regions that overlapped each other by 200 nucleotides. Of these seven
regions, only Regions 1–4 had reproducible patterns of lacZ expression (B–E). Embryos with Regions 5 and 8 had unreproducible patterns of lacZ expression, whereas
embryos bearing Region 7 produced no lacZ expression at the time points examined. Region 6 was not propagatible in bacteria and therefore not tested for regulatory
activity. The white arrowhead points to the proepicardial organ (PEO) (C–D), while the black arrow indicates the dorsal aorta and the open arrow points to lacZ stained cells
within the medial aspect of the developing heart (E).
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isolate and characterize discrete or individual modular regulatory
components contained within these regions we felt it was impor-
tant to assess what contributions they made to the overall pattern
of expression observed in the transposon-lacZ BAC reporter assay.
Therefore, we generated an additional set of BAC transposon
reporters, that deleted these newly identiﬁed regions in the
presence or absence of the three previously identiﬁed enhancers
3′ of Hoxb1, using TI-1 as the base vector (Fig. 6). Removal of
Regions 2–4 (TI-1 Δ2–4), produced a pattern of lacZ expression
that closely resembled the original TI-1 BAC construct (Fig. 6). This
would be consistent with the idea that this pattern can be driven
by the known 3′ mesoderm and endoderm enhancers of the Hoxb1
gene. However, when both the known 3′ Hoxb1 enhancers and
Regions 2–4 are deleted from this BAC transgenic reporter (TI-1Δ3′
Δ2–4), expression was completely abolished. These results under-
score the contributions of Regions 2–4 and reveal a considerable
degree of overlap with respect to the regulatory potential of both
the local 3′ elements and those contained within Regions 2–4.
Each appears capable of compensating for the loss of the other, but
when both are deleted from the regulatory landscape adjacent to
the HoxB complex, reporter expression is abolished. Therefore,
Regions 2–4 may function as shadow enhancers with overlapping
activities to the local cis-acting elements of Hoxb1 which together
could confer robustness in regulatory input (Hong et al., 2008;
Perry et al., 2010). Alternatively, all of these regions could be
working in concert as part of a larger “holo-enhancer”, as has been
proposed for the Fgf8 gene (Marinic et al., 2013).
RAREs in the enhancers
In view of the important role for retinoids in heart develop-
ment and modulation of Hox gene expression, we performed
Fig. 4. Further reduction of the 10 kb subclones into smaller regions abolished reporter activity. (A) Comparison of the 10 kb reporters that had reproducible lacZ expression
patterns (excluding Region 1) against a subset of the original Hoxb1-Skap1 VISTA analysis shown in Fig. 1 reveals that these regions contained blocks of sequence
conservation. (B) A series of successive 3′ truncations of Regions 2–4 were generated, but the majority of them failed to produce lacZ expression. Only subclone 4A produced
lacZ expression (Fig. 5) but had different dynamics that the pattern produced by Region 4 from which it was derived. VISTA analysis indicated that the 3′ end of Region
3 contained a large block of sequence conservation. This region was added to 4A to produce the HGE subclone which produced lacZ expression from E9.5 onwards (Fig. 5).
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Fig. 5. Several regions downstream of the HoxB complex had dynamic expression patterns in the endoderm and tissues contributing to the developing heart. β-Galactosidase
activity for Regions 3 and 4, and their derivatives (subclone 4A and subclone HGE) were examined from E8.5 to E11.5. At E8.5, Region 3 produced lacZ expression in the SHF
(indicated by black, square brackets) while subclone 4A produced expression in the anterior intestinal portal (indicated by a black chevron).
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sequence analysis to search the entire intergenic region for the
presence of RAREs. We detected two DR2 RAREs, one located in
Region 3 and one in Region 4 (Fig. 7). The location of these RAREs
raised the possibility that they contribute to the regulatory
potential of these enhancers. Hence, we tested whether exogen-
ously added RA alters reporter behavior in transgenic embryos
carrying Region 3 and the HGE. Both Regions 3 and the HGE
mediate a response to excess RA but the timing and type of
response is different between the two (data not shown). We then
mutated each putative RARE within these reporter constructs by
converting the nucleotide sequences of the direct repeats to
strings of adenines. Mutation of the DR2 RARE in Region 3 resulted
in a signiﬁcant decrease in reporter staining, while the mutation of
the DR2 RARE in the HGE resulted in a greatly expanded pattern of
reporter staining (Fig. 7). These ﬁndings suggest that RA signaling
mediated through these RAREs plays a role in activity of the
enhancers.
Analysis of the regulatory potential of the region ﬂanking the HoxA
complex
The HoxA and HoxB complexes arose by duplication and
divergence from a common ancestor and the combined action of
these duplicate clusters is speciﬁcally required for correct heart
looping (Soshnikova et al., 2013). Therefore, based on the new
heart and endodermal regulatory regions ﬂanking HoxB identiﬁed
above, we explored whether similar regulatory regions exist
adjacent to the HoxA complex. To search for conservation between
the intergenic regions ﬂanking HoxA and HoxB, we performed a
series of VISTA alignments (Fig. 8A). Comparison of the 3′ ﬂanking
intergenic regions from the mouse HoxB and HoxA complex
revealed very few regions of sequence conservation (Fig. 8A).
Looking speciﬁcally for similarities to Regions 2–4 of HoxB, we
observed little if any sequence conservation. Sequence compar-
isons in placental mammals of the region ﬂanking the HoxA
complex itself shows a high degree of overall conservation spread
throughout the 3′ intergenic region (Fig. 8B). This level of
sequence conservation is not found when comparing the ortholo-
gous region of non-placental vertebrates (Fig. 8C). This is analo-
gous to the type of overall conservation we observed in the
intergenic region adjacent to HoxB in placental mammals
(Fig. 1B). However, there is no signiﬁcant overlap or similarity in
the sequence proﬁles between the HoxA and HoxB clusters that
points to the presence of potentially constrained regulatory
regions shared by the sister clusters.
Since the regulatory activities of the regions ﬂanking the HoxB
complex in endoderm and heart tissues were located within
approximately 40 kb of Hoxb1, we assayed the regulatory potential
of similar regions ﬂanking the HoxA complex by testing a series of
10 kb reporter constructs in transgenic mice (Fig. 9). Transgenic
lines were generated with HoxA Regions 1, 3 and 4 but Region
2 was not propagable in bacteria (Fig. 10). Region 1 contains
Fig. 6. The regions with novel enhancer activity function as shadow enhancers to the local Hoxb1 enhancers. The original TI-1 reporter underwent three modiﬁcations. In the
ﬁrst modiﬁcation, the local 3′ enhancers of Hoxb1 were deleted (as previously shown in Fig. 2). In the second modiﬁcation an area encompassing Regions 2–4 was deleted
(TI-1 Δ2–4). In the ﬁnal modiﬁcation, both the local 3′ enhancers and the area encompassing Region 2–4 were deleted (TI-1Δ3′ Δ2–4). Deletion of both these regions
abolished reporter expression. The black arrowhead indicated the foregut domain of expression driven by the local Hoxb1 3′ enhancers.
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a previously characterized RARE-dependent neural enhancer
required for early Hoxa1 expression (Dupé et al., 1997). This
reporter produced a pattern of lacZ expression in ectoderm and
mesoderm at E8.5 very similar to endogenous Hoxa1 expression,
indicating that a mesodermal enhancer also resides within Region
1 (Fig. 10). However at later stages (E9.5–10.5) reporter expression
stays on in the trunk and appears in forebrain regions at a time
when endogenous Hoxa1 is no longer expressed. This suggests that
additional components or context within the ﬂanking region may
serve to restrict the activity of Region 1. Regions 3 and 4 adjacent
to HoxA produced no lacZ expression from E8.5 to E9.5, however
widespread expression was observed with Region 4 at E10.5
(Figs. 9 and 10). Hence, in addition to the lack of sequence
similarity between intergenic regions adjacent to HoxA and HoxB,
in HoxA there does not appear to be functionally equivalent cis-
regulatory elements in a position similar to Regions 3 and 4 ﬂank-
ing HoxB.
We also scanned the HoxA-Skap2 intergenic region for search
for novel RARE sequences and identiﬁed four potential elements
(Fig. 9B, purple arrowheads above the VISTA proﬁle). Three of
these RAREs are clustered in a region spanning the 3′ end of
Region 1 and the 5′ end of Region 2. This cluster of RAREs
downstream of the Hoxa1 gene suggested that some type of
regulatory potential may reside in this region. Since the entire
HoxA Region 2 was not propagable in bacteria, we generated a
smaller subclone (HoxA Region 2A) that contained the three
clustered RAREs (Fig. 9). This construct produced strong lacZ
expression throughout the endoderm and mesoderm from E8.5
to E10.5 (Fig. 10). Furthermore, when the heart was dissected at
E10.5, lacZ expression domains clearly marked SHF derivatives,
including the OFT and atria (Fig. 9). These regions marked by the
HoxA Region 2A reporter in the developing heart corresponded to
territories previously identiﬁed as being populated by Hoxa1 and
Hoxa3-expressing progenitors from the SHF (Bertrand et al., 2011).
A transverse section of an E10.5 embryo expressing the HoxA
Region 2A reporter showed that lacZ expression was mainly
restricted to the myocardial layer of the heart (Fig. 9).
In summary, these analyses have shown that the 3′ ﬂanking
regions adjacent to HoxA and HoxB have the regulatory potential to
modulate expression in endoderm and heart tissues, which may
be associated with the functional role of these two clusters in
heart looping. While the enhancers all have RAREs and may
integrate aspects of retinoid signaling, the regions ﬂanking the
HoxA and HoxB complex do not appear to have a similar comple-
ment of conserved and ordered cis-regulatory elements spread
throughout the intergenic regions which might be representative
of heart or endodermal control regions present prior to duplica-
tion of these sister clusters.
Discussion
Analyses of the expression and function of Hox genes has
demonstrated that they play an important role in modulating
aspects of the cardiac developmental program (Bertrand et al.,
2011; Chisaka and Capecchi, 1991; Makki and Capecchi, 2012;
Soshnikova et al., 2013). However, very little was known about the
cis-regulation that underlies these patterns of expression and
function. In this study, we present regulatory analyses of the
HoxA and HoxB complexes revealing that both contain multiple
enhancers in their 3′ ﬂanking intergenic regions capable of
directing expression in endoderm and heart tissues over a long
Fig. 7. Identiﬁcation and testing of novel retinoic acid response elements (RAREs). Two novel DR2 RAREs within Regions 3 and 4 (subclone HGE) were identiﬁed based on
sequence. Their approximate positions within the BAC are displayed as vertical purple bars. Below the BAC map, the sequence of each DR2 RARE is indicated. Mutation of
these putative RAREs within these reporters either diminishes (Region 3 RARE) or increases (HGE subclone RARE) lacZ expression.
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range. The control modules in the HoxB complex are spread
throughout the ﬂanking intergenic region, display complex orga-
nization and have some degree of overlapping activity with local
enhancers suggesting that they may function as shadow enhan-
cers. These enhancers have RAREs implying that retinoid signaling
serves to directly integrate Hox gene expression with cardiogen-
esis. Together our ﬁndings provide insight for understanding
features of the regulatory landscape of Hox clusters and ﬂanking
intergenic regions during vertebrate evolution with respect to
their roles in endoderm and heart development. These data
support a regulatory model whereby the conserved control mod-
ules ﬂanking the HoxA and HoxB clusters act over a long range on
multiple Hox genes to generate their nested patterns of expression
during cardiogenesis.
Novel endoderm and heart enhancers
Our analyses have uncovered multiple regions that displayed
discrete localized cis-regulatory activity in endoderm and heart
tissues. When the 3′ ﬂanking region of the HoxB complex was
broken up into 10 kb fragments, enhancer activity for the visceral
endoderm, visceral mesoderm and septum transversum were
segregated away from that of the presomitic and somitic meso-
derm. Only Region 1 produced lacZ expression in these latter
domains, whereas Regions 2–4 produced novel patterns of lacZ
expression in the PEO, epicardium, visceral endoderm and visceral
mesoderm (Fig. 3). The enhancers located at the 3′ end of the HoxA
complex also mediated reporter staining in PEO, visceral endo-
derm and visceral mesoderm at E.9.5 and in SHF derivatives (OFT
and atria) at E10.5. The HoxA Regions 1 and 2A enhancers also
direct reporter expression in a variety of other tissues, including
neural ectoderm and mesoderm (Figs. 9 and 10). These patterns
are similar to those mediated by the three previously character-
ized Hoxb1 enhancers (Region 1) located in a similar position at
the 3′ end of the HoxB complex. Based on position and activity
there seems to be some commonality between the regulatory
regions immediately ﬂanking the HoxA and HoxB complexes.
However, HoxB has additional enhancers spread throughout the
more distal intergenic region.
Regulatory complexity and long range activity of ﬂanking enhancers
We attempted to break these enhancers down into smaller
modules by deletion analysis to facilitate the characterization of
cis-regulatory elements and transcription factor binding motifs
which potentiate their activities. Unlike the modular enhancers
previously characterized for Hox gene expression in neural and
mesodermal tissues (Alexander et al., 2009; Tumpel et al., 2009),
Fig. 8. The VISTA proﬁle of the intergenic region ﬂanking the HoxA complex is different than the proﬁle of the paralogous region ﬂanking the HoxB complex. (A) Comparison
of the mouse intergenic regions ﬂanking the HoxB and HoxA complexes reveal few areas of sequence conservation. (B) VISTA analysis of the intergenic region ﬂanking the
HoxA complex of placental mammals reveals multiple blocks of sequence conservation. Displayed above this VISTA proﬁle are constructs generated for lacZ reporter analysis
in transgenic assays (Fig. 9). Displayed about the VISTA proﬁle is the known Hoxa1 neural RARE (red triangle) as well as four purple triangles corresponding to potentially
novel RAREs. Three of these elements reside within the 2A region. (C) The intergenic region ﬂanking the HoxA complex has poor sequence conservation when compared
against non-placental vertebrates.
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further reduction of the enhancers identiﬁed in this study
generally led to either a loss or change in activity (Fig. 4). For
example, HoxB Region 4 generated lacZ expression in the dorsal
aorta, whereas the 4A 5′ subfragment produced expanded reporter
staining in the epicardium (Fig. 5). Collectively these results imply
that multiple cis-elements spread throughout the 10 kb enhancer
regions work in combination to modulate regulatory activity.
Consistent with this type of complexity, some of the isolated
individual enhancers display regulatory activity different from that
observed when they were in the full context of the HoxB BAC
carrying the transposon reporters. This is illustrated by HoxB
Region 3, which as an isolated enhancer directs robust lacZ
expression in the visceral ectoderm as well as in the lateral
mesoderm (Figs. 3D and 5). However, in the context of the BAC,
TI-2 and TI-3 display more restricted domains of expression in
these tissues (Fig. 2B). Therefore, the enhancers in Region 2–4
ﬂanking HoxB cluster appear to be dependent upon context to
properly mediate the appropriate domains of expression.
In the HoxA analysis, Regions 1 and 2A directed reporter
expression at E8.5 with anterior boundaries and tissue speciﬁcity
that closely resemble the pattern of the endogenous Hoxa1 gene.
However, at later stages reporter expression persists and appears in
Fig. 9. Transgenic analyses at E9.5 of the regions ﬂanking the HoxA complex show that they have different regulatory potentials. HoxA's Region 1 contains the Hoxa1 neural
RARE and produces expression throughout the trunk as well as in the forebrain. HoxA Regions 3 and 4 produced no reporter activity at E9.5. HoxA Region 2 was not tested,
but a subclone of it (2A) containing a portion of the 3′ end of Region 1 produced robust expression throughout most of the trunk mesoderm and endoderm as well as in the
developing heart. In the E10.5 heart, the 2A region produced lacZ expression in many of the SHF derivatives of the heart. A transverse section through the E10.5 transgenic
heart shows that lacZ expression of HoxA Region 2A reporter was restricted primarily to the myocardium.
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ectopic domains (Fig. 10) indicating that both the pattern and
timing of these regulatory regions no longer correlate with Hoxa1
expression. This suggests that either additional elements or the
context within the HoxA ﬂanking region maybe important in
restricting the pattern and timing of these regulatory regions.
The inability to break these regions down into modular units and
their context dependence suggest that these enhancers are part of an
extended regulatory landscape necessary to properly potentiate their
activity. Conceptually this could be considered to be a holo-enhancer
analogous to that described for the Fgf8 gene (Marinic et al., 2013).
In this model, the output of multiple enhancers spread over a broad
region depends upon their position or context to regulate the
intrinsic activities of the regulatory components as a coherent unit.
This type of context dependent activity could involve differential
looping to produce dynamic and speciﬁc transcriptional readouts.
By analyzing individual enhancers or reducing them into smaller
fragments in our assays, the local chromatin architecture maybe
disrupted resulting in different regulatory outcomes.
Fig. 10. Temporal time course of the enhancer potential of the HoxA regions in transgenic mouse embryos from E8.5 to E10.5. HoxA's Region 1 produced expression
throughout the trunk mesoderm and endoderm from E8.5 to E10.5, with lacZ intensity decreasing at E10.5. Region 2A produced robust lacZ expression throughout the trunk
mesoderm and endoderm from E8.5 to E10.5, but became progressively excluded from the developing posterior trunk. Region 3 produced no lacZ expression at all stages
examined. Region 4 had no early enhancer activity, producing lacZ expression only in E10.5 embryos throughout deﬁned regions that included neural tissues, rostral somites
and visceral endoderm.
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It is an attractive possibility to think that collectively these 3′
ﬂanking enhancers could function globally over the HoxB complex
to direct expression of multiple Hox genes. This suggests a
mechanism whereby long range interactions of these enhancers
could be shared by multiple genes to create the endogenous
domains of nested Hox expression in the SHF. We found evidence
that some of these enhancers can work over long range. In the
HoxB BAC reporter assays, the regulatory inﬂuence of the enhan-
cers extended throughout the intergenic region towards the Skap1
gene, as the lacZ reporter transposed at 10 kb, 21 kb, 26 kb, 52 kb
and 64 kb downstream of the Hoxb1 gene produced a similar
pattern of expression (Fig. 2). In contrast, the Hoxb1 3′ endoderm
enhancer has a limited range of inﬂuence, since it could only
activate the lacZ reporter in TI-1 (4.4 kb distance) and fails to work
on the more distal transposon reporters.
Shadow enhancers
Despite the context dependence and complexity of the organi-
zation of the enhancers ﬂanking the HoxB complex, we uncovered
regions that had a considerable degree of overlap in their ability to
regulate expression. Furthermore, only deletion of both Regions 2–
4 and the three previously identiﬁed enhancers 3′ of Hoxb1
(Region 1) eliminated reporter activity (Fig. 6). The overlap in
activity and functional compensation in BAC assays imply that
Regions 2–4 may function as shadow enhancers to the local cis-
acting enhancers 3′ of Hoxb1. In view of the dynamic regulation of
Hox genes during these stages of cardiac development, the
purpose of these shadow enhancers could be to ensure robustness
and appropriate timing of HoxB expression in these tissues (Hong
et al., 2008; Perry et al., 2010). Our experiments suggest that there
may also be shadow enhancers for the presomitic mesoderm.
Region 1 contains a mesodermal enhancer of Hoxb1 (Marshall
et al., 1994). However, deletion of this region in BAC assays still
displayed reporter expression in the presomitic mesoderm indi-
cating that other enhancers in Regions 2–4 contribute to the
mesodermal expression proﬁle (Fig. 6).
Upstream regulators: RA signaling
Despite the fact that these regulatory regions were broadly
dispersed throughout the 3′ ﬂanking intergenic region, we used
the conservation and regulatory activity as a basis to search for
potential upstream regulators that may potentiate enhancer activ-
ity. For both the HoxA and B clusters, RAREs appear to play an
integral role in the regulatory activity of the enhancers. The two
novel RAREs characterized in the HoxB ﬂanking region appear to
have different activities. The RARE in Region 3 correlates with a
role in activation, as mutation of its RARE results in signiﬁcant
down-regulation in reporter activity (Fig. 7). Conversely, the RARE
of Region 4/HGE is consistent with a role in repression as mutation
of the RARE results in dramatic up-regulation in reporter staining.
These differences are consistent with the multiple roles of RA
signaling in establishing the precise boundaries of the cardiac
ﬁelds (Buckingham et al., 2005; Vincent and Buckingham, 2010).
Evolution of regulatory features in HoxA and HoxB sister clusters
The maintenance of the clustered organization of Hox genes is
believed to be in part due to regulatory constraints associated with
features such as, colinearity, the action of long range global
regulatory elements and enhancer sharing (Kmita and Duboule,
2003; Noordermeer and Duboule, 2013). The complex architecture
of the regulatory landscape revealed by our analysis of ﬂanking
regions of the HoxB complex is consistent with this idea. If the
shadow enhancers and context dependent organization of this
broad intergenic region are essential to mediate the ordered
expression of multiple HoxB members in endoderm and cardiac
development, they would place a regulatory constraint on dis-
rupting the complex and 3′ ﬂanking region.
The speciﬁc functional requirement for the combined action of the
HoxA and the HoxB complexes for correct heart looping, suggested that
a novel cis-element or module present in the A/B ancestor cluster may
have been maintained in the sister copies during duplication of the
cluster in vertebrate evolution (Soshnikova et al., 2013). Using phylo-
genetic footprinting analyses in both placental and nonplacental
vertebrates, we did not detect areas of sequence conservation which
would be candidates for such an ancestral element. However, our
regulatory analyses did highlight functional similarities between the
regions immediately ﬂanking the 3′ end of the HoxA and the HoxB
clusters. The Region 1 fragments from both clusters produced very
similar patterns of reporter expression in neural ectoderm, mesoderm
and endoderm (Figs. 3B and 9). These regions contain neural enhan-
cers with RAREs required for the expression of Hoxa1 and Hoxb1
(Dupé et al., 1997; Marshall et al., 1994; Studer et al., 1998). While it
was known that a mesodermal and an endodermal enhancer were
adjacent to the neural enhancer in HoxB, our analysis uncovered
similar regulatory potential to modulate expression in mesoderm and
endoderm in the corresponding region adjacent to the HoxA. Further-
more, we found a new cluster of RAREs within this HoxA regulatory
region which may be analogous to the RARE found in the HoxB
endoderm enhancer (Huang et al., 1998). While we did not ﬁnd
extensive sequence conservation between the HoxA and HoxB com-
plexes in this region, the relative positions adjacent to the complexes,
the functional/regulatory similarities and the presence of RAREs
suggest that these may have evolved by duplication and divergence
from a common ancestor. The absence of extended sequence con-
servation may be a consequence of the fact that the precise order and
number of binding sites for key upstream factors in many enhancers
can vary considerably during evolution (Moses et al., 2006).
The endodermal and heart enhancers we identiﬁed in Regions
2–4 in the HoxB complex do not appear to have equivalent
counterparts ﬂanking the HoxA complex, although we have not
characterized the complete intergenic region between HoxA and
Skap2 which is much larger than that between HoxB and Skap1.
Hence, the HoxB shadow enhancers appear to be speciﬁc to the
HoxB complex, arising after duplication of the A/B sister com-
plexes. Our results on the similarities in location, enhancer output,
and dependence on retinoid signaling suggest a model in which
the proximal 3′ enhancers adjacent to the HoxA and HoxB complex
may have arisen from a common ancestor and play primary roles
in endodermal and cardiac regulation of Hox genes. The shadow
enhancers in Regions 2–4 of HoxB may then make a contribution
by reinforcing the timing, robustness or adding new domains to
these patterns of expression. Together our analyses suggest a
common regulatory mechanism, whereby the conserved control
modules act over a long range on multiple Hox genes to generate
nested patterns of HoxA and HoxB expression during cardiogenesis
essential for proper looping of the heart.
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